Abbott Laboratories R&D Expenses 2015-2019.
|Year||R&D expenses ($mn)|
The research and development expenses of Abbott Laboratories in 2019 grew to $2,440 million compared to $2,300 million in 2018.
About the Abbott Laboratories:
Founded in 1888, Abbott Laboratories is a global healthcare brand with operations across more than 160 countries. The name of its founder was Dr. Wallace C. Abbott. The company employs more than 107,000 people, and its products span the following categories – 1. Cardiovascular 2. Diabetes 3. Diagnostics 4. Neuromodulation 5. Nutrition 6. Pharmaceuticals.
The net sales of Abbott Laboratories in 2019 reached $31.9 billion compared to $30.6 billion in 2018. Its net earnings reached $3.7 billion in 2019 compared to $2.3 billion in 2018. The United States is the largest market for Abbott Products accounting for more than one-third of its net sales in 2019. Abbott Laboratories generated $11.4 billion in 2019 compared to $10.84 billion in 2018 from the United States market alone. Medical devices are the largest product category of Abbott. The revenue of Abbott laboratories from the sales of medical devices in 2019 was $ 12.24 billion compared to $11.4 billion in 2018.
Mission Statement of Abbott Laboratories:
“LIVE YOUR BEST LIFE, NOW AND IN THE FUTURE.”
“We understand that the first step to living your best life is good health. Everything we make is designed to help you do just that. That’s our commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines, and breakthroughs to manage your health.” (About Abbott)